Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Genmab A (GMAB) Equity Ratio (2023 - 2025)

Historic Equity Ratio for Genmab A (GMAB) over the last 3 years, with Q4 2025 value amounting to 0.45.

  • Genmab A's Equity Ratio fell 4328.83% to 0.45 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.45, marking a year-over-year decrease of 4328.83%. This contributed to the annual value of 0.45 for FY2025, which is 4328.83% down from last year.
  • Genmab A's Equity Ratio amounted to 0.45 in Q4 2025, which was down 4328.83% from 0.82 recorded in Q3 2025.
  • Genmab A's 5-year Equity Ratio high stood at 0.9 for Q4 2023, and its period low was 0.45 during Q4 2025.
  • Over the past 3 years, Genmab A's median Equity Ratio value was 0.8 (recorded in 2024), while the average stood at 0.78.
  • Within the past 5 years, the most significant YoY rise in Genmab A's Equity Ratio was 230.33% (2025), while the steepest drop was 4328.83% (2025).
  • Genmab A's Equity Ratio (Quarter) stood at 0.9 in 2023, then fell by 10.6% to 0.8 in 2024, then tumbled by 43.29% to 0.45 in 2025.
  • Its last three reported values are 0.45 in Q4 2025, 0.82 for Q3 2025, and 0.82 during Q2 2025.